Nguyen Thu-Tinh, Nguyen Oanh T H, Duong Mai N, Giang Linh Tran Phuong
Pediatrics, University of Medicine and Pharmacy, Ho Chi Minh City, VNM.
Neonatology, University Medical Center, Ho Chi Minh City, VNM.
Cureus. 2024 Jul 2;16(7):e63704. doi: 10.7759/cureus.63704. eCollection 2024 Jul.
The traditional approach to neonatal early-onset sepsis (NEOS) management, involving maternal risk factors and nonspecific neonatal symptoms, usually leads to unnecessary antibiotic use. This study addresses these concerns by evaluating the Kaiser sepsis calculator (KSC) in guiding antibiotic therapy for NEOS, especially in high-incidence facilities (over 4/1,000 live births), by comparing it against the 2010 Centers for Disease Control and Prevention (CDC) guidelines for neonates ≥34 weeks with suspected sepsis, thereby emphasizing its implications for personalized patient care.
This is a prospective observational study. All neonates of 34 gestational weeks or more, presenting with either maternal risk factors or sepsis symptoms within 12 hours of birth, were included in the study. The analysis focused on antibiotic recommendations by the 2010 CDC guidelines versus those by the KSC at presumed (0.5/1,000) and actual (16/1,000) sepsis incidence rates.
NEOS was identified in 14 cases (14.1%). Compared to the KSC, at an incidence rate of 16 per 1,000, the KSC resulted in a significant 32.3% reduction in antibiotic treatment (74 cases (74.7%) vs. 42 cases (42.4%), respectively; p < 0.001). The calculator advised immediate antibiotic utilization for 13 out of 14 (92.9%) diagnosed cases, suggesting further evaluation for the remaining cases. When a presumed incidence of 0.5/1,000 was applied, the KSC indicated antibiotics less frequently than when using the actual rate of 16/1,000 (p<0.001) with two missed NEOS cases.
Using the KSC led to a decrease of 32 cases (32.3%) in unnecessary antibiotic prescriptions compared to adherence to 2010 CDC guidelines. However, setting a presumed incidence below the actual rate risked missing NEOS. The calculator was effective when actual local incidence rates were used, ensuring no missed cases needing antibiotics.
新生儿早发型败血症(NEOS)的传统管理方法涉及母体风险因素和非特异性新生儿症状,通常会导致不必要的抗生素使用。本研究通过评估凯泽败血症计算器(KSC)在指导NEOS抗生素治疗中的作用来解决这些问题,特别是在高发病率机构(活产率超过4/1000)中,将其与2010年疾病控制与预防中心(CDC)针对疑似败血症的≥34周新生儿的指南进行比较,从而强调其对个性化患者护理的意义。
这是一项前瞻性观察性研究。所有孕34周或以上、在出生后12小时内出现母体风险因素或败血症症状的新生儿均纳入研究。分析重点在于2010年CDC指南与KSC在假定(0.5/1000)和实际(16/1000)败血症发病率下的抗生素推荐。
共确诊14例NEOS(14.1%)。与KSC相比,在发病率为每1000例中有16例时,KSC使抗生素治疗显著减少32.3%(分别为74例(74.7%)和42例(42.4%);p<0.001)。该计算器建议对14例确诊病例中的13例(92.9%)立即使用抗生素,提示对其余病例需进一步评估。当应用假定发病率0.5/1000时,KSC提示使用抗生素的频率低于实际发病率16/1000时(p<0.001),且有2例NEOS漏诊。
与遵循2010年CDC指南相比,使用KSC可减少32例(32.3%)不必要的抗生素处方。然而,将假定发病率设定低于实际发病率有漏诊NEOS的风险。当使用实际当地发病率时,该计算器有效,可确保无需要抗生素治疗的病例漏诊。